SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-120337
Filing Date
2022-11-18
Accepted
2022-11-18 16:30:44
Documents
13
Period of Report
2022-11-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2230860d1_8k.htm   iXBRL 8-K 25863
2 EXHIBIT 10.1 tm2230860d1_ex10-1.htm EX-10.1 9896
  Complete submission text file 0001104659-22-120337.txt   212452

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nviv-20221117.xsd EX-101.SCH 3063
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nviv-20221117_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nviv-20221117_pre.xml EX-101.PRE 22615
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2230860d1_8k_htm.xml XML 3622
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37350 | Film No.: 221402331
SIC: 3841 Surgical & Medical Instruments & Apparatus